CV

If you would like to see my full CV it’s available here.

Articles

Chemical Coping and the Role of Palliating Existential Suffering: A Case Study

with: G.S. Mastroleo and A. Palmer

While palliative medicine has a clear mandate to address the somatic suffering of patients, it remains less clear how palliative medicine should intervene—if at all—in the management of existential suffering. We detail the case of a patient with terminal gastrointestinal cancer. Through consideration of this case, we make determinations regarding what is ethically required, as well as ways in which these implications may generalize to appropriately similar cases. Specifically, we draw two conclusions. First, standard risk-benefit calculus must be recalibrated to account for the irrelevance of certain imagined harm in imminently terminal cases. Additionally, respect for autonomy in the context of a “good death” entails respecting consistent, well-considered preferences on the part of the patient.

Available in The Journal of Clinical Ethics.

Marketing Cancer Care: A Content Analysis of Ethical Compliance in Television Advertising by Top-Ranked U.S. Cancer Centers

with: A. Palmer

Direct-to-consumer advertising (DTCA) in cancer care targets vulnerable patient populations and can significantly influence treatment decisions. Despite established ethical guidelines for healthcare advertising, concerns persist about marketing practices in oncology. We reviewed television advertisements broadcast between 2019-2024 from the top 20 U.S. cancer centers as ranked by U.S. News & World Report. We evaluated these advertisements against ethical guidelines from major medical bodies. All of these ethical guidelines had been published before the advertisements were released. Both authors independently classified advertisements as compliant, borderline, or transgressive based on adherence to established ethical standards. Advertisements were considered transgressive if they explicitly violated guidelines, while borderline cases contained claims subject to multiple interpretations, at least one of which would violate guidelines. Despite widespread agreement on ethical guidelines for cancer care advertising, many leading institutions continue to produce advertisements that may mislead vulnerable patients. Our findings suggest the need for better promulgation and enforcement of ethical standards in cancer care marketing. Future research should investigate mechanisms for improving compliance with ethical guidelines and ensuring that cancer care advertising serves its proper role of informing rather than potentially misleading patient decision-making.

Available in The Journal of Cancer Policy

Trends in Ethical Transgressions Amongst South African Dietetic Practitioners

with: M. Pontarelli, J. Wilkenson, Y. Gezu, M. Nortje, G. Truong, N. Ravi, N. Nortje, and W.A. Hoffmann

This study investigated ethical transgressions amongst dietetic practitioners in South Africa, using publicly available data from the Health Professions Council of South Africa (HPCSA) in the period 2014 to 2023. The study is a follow-up on the study by Nortje and Hoffmann (2015) who analyzed HPCSA transgression records for the period 2007 to 2013. The current study found only five transgressions committed by two dietitians out of 1,376 cases across all HPCSA-registered professions. In total, amongst the more than 4,200 registered dietetic practitioners in 2024, this constitutes a transgression rate of <0.05% (2 of ~4,190), a decline from the previously reported 0.24% in 2013.

While we consider possible explanations for the apparent decline in transgressions, no definitive conclusion is reached. Despite limitations, the findings highlight consistently low misconduct rates among dietitians over the past two decades, potentially positioning the field as a model for ethical adherence in healthcare. We recommend future research be conducted to explore factors driving the high rate of ethical compliance in dietetics and its potential application across other healthcare professions.

Available in the South African Journal of Clinical Nutrition

Talks

Salutogenic Medicine and Expressive Autonomy

In recent bioethics literature, some have argued for an increasingly “salutogenic” model of medicine, focused on promoting wellbeing, as contrasted with a “pathocentric” model of medicine which focuses on combating disease, disability, and dysfunction. I propose that a wellbeing-oriented model of medicine will invariably need to accommodate a patient’s self-conception and be responsive to their understanding of what wellbeing means to them personally. While this position broadly is not novel, I motivate the claim that this can be facilitated by (and is evidence for) adopting what I have termed “expressive autonomy.” Expressive autonomy is the notion that patients not only have medical autonomy in the traditional sense but also have a distinct right to determine for themselves how they wish to be presented to the world. So significant is the right to expressive autonomy that it may render permissible behaviors which are counterintuitive to evidence-based medical judgement, including smoking and elective amputation, and controversial forms of self-identification such as being gender-nonconforming or trans-able. Despite the potential implications of this view, I maintain that it rests only on a few plausible assumptions about what the purpose of medicine is and what rights people have over their own bodies and the way those bodies interact with various aspects of public life. By recognizing the right to expressive autonomy, we can make better sense of cases in which patients-directed goals of care are shocking or even potentially distressing to clinicians. This is not to say that expressive autonomy applies to all cases or that it overrides other important considerations such as duty to care, just allocation of scarce resources, and so forth. Rather, expressive autonomy should be given due consideration as part of a pluralistic and nonhierarchical model of bioethics as more conventional principles like beneficence and justice already are.

Presented in 2026 at the Dorothy J. MacLean Clinical Ethics Conference

Marketing Cancer Care: A Content Analysis of Ethical Compliance in Television Advertising by Top-Ranked U.S. Cancer Centers

Direct-to-consumer advertising (DTCA) in cancer care influences patient decisions but often targets vulnerable populations. Despite established ethical guidelines, adherence remains understudied. This study evaluates how well top U.S. cancer centers comply with these standards in television advertisements. We analyzed 31 TV ads from 2019 to 2024 produced by members of the top 20 cancer centers as ranked by U.S. News & World Report, comparing them against ethical guidelines from the American Medical Association, American Society of Clinical Oncology, and others. Two independent reviewers categorized ads as compliant, borderline, or transgressive. Transgressive ads explicitly violated guidelines, while borderline cases contained ambiguous claims with at least one problematic interpretation. Of the 31 ads from 12 institutions, 16 (52%) were either transgressive or borderline. Only 4 of 12 (33%) institutions produced exclusively compliant ads. Common issues included unrealistic expectations (36%), implying exclusive treatment availability (13%), and unclear eligibility criteria (13%). Notably, institutions ranked in the top 10 produced 71% of the ads and were responsible for 8 of 9 transgressive cases. The prevalence of transgressive advertising suggests that ethical guidelines alone are insufficient. Potential solutions include increasing awareness among marketing leadership and enforcing compliance, possibly as a hospital accreditation requirement. As cancer care continues to advance and treatment options become more complex, ensuring ethical advertising practices is crucial for supporting informed patient decision-making and maintaining public trust in healthcare institutions.

Presented in 2025 at the American Society for Bioethics and Humanities 27th Annual Conference

Pain Management as a Failed Proxy for Wellbeing

In clinical settings across the industrialized world, it has become standard practice to record patients’ self-reported levels of pain. Advocates of the practice note it enables the tracking of patients’ pain levels over time, adding another metric for evaluating patient progress. I argue that rather than providing more insights into patient wellbeing, numerical rating scales (NRSs) of patient pain strips nuance out of clinical understandings of wellbeing. I contend that NRSs constitute an instance of what has come to be known as “value capture.” This value capture has collapsed the richly-textured (and at times, ineffable) notions of wellbeing which clinical practitioners might hold into a single number at the patient’s expense. I argue for three claims: (1) NRSs frequently become genuine instances of value capture as Nguyen would describe it; (2) such instances constitute possible harms to patients by collapsing more reliable metrics of success; and (3) it is therefore in patients’ best interests to not report their pain levels unless they are seeking analgesics. The first claim is motivated by revisiting Nguyen’s original account of value capture and considering this in the context of both how NRSs are used in practice and the history of their implementation. The second claim is motivated by contrasting the effects achieved through managing patients’ levels of pain and the goals of medicine consistent with other popular accounts of wellbeing. The third claim follows from the first two. I ultimately conclude that the practice of automatically soliciting this information from patients is detrimental to the goals of medicine and, until there is systemic change about this, patients can advocate for their own wellbeing by requesting their pain not be recorded on a NRS.

Presented in 2025 at the Toronto Workshop on Bioethics

Maturing Beyond “If it Works, it Works” in Practice

Traditionally, the ultimate metric of efficacy for a medical treatment has been clinical significance. Through case studies—particularly those of thalidomide and MAOIs—I explore the deficiencies of relying on mere clinical study, highlighting instead the value of holding out for an identifiable mechanism-of-action. I provide an operational definition of mechanism of action (MOA). Using this, I argue that, if we take the principles of informed consent seriously, we ought to be extremely conservative in our approval and prescription of treatments for which we have yet to identify the MOA. This is not meant to motivate a reconsideration of existing drug approvals, but rather to raise the bar for future treatment options in the interest of balancing practical demands (vis-à-vis immediate patient needs) and long-term health and safety. I briefly consider two kinds of objections, which I divide into the clinical and the philosophical  for which I offer rebuttals. Read more.

Presented in 2024 at the Boston University Graduate Conference on the Philosophy of Science

An increasing number of communities have found themselves dependent on Catholic providers of acute care. As such, if the Church accepts advice against a certain form of treatment, a de facto ban on that treatment is then in place. This has proven to be the case for puberty blockers as a treatment for gender non-conforming youth. I argue that the typical prohibition on this treatment—that puberty blockers are tantamount to gender transition, which is prohibited—fails because puberty blockers are neither necessary nor sufficient for transition. Moreover, if puberty blockers are not prohibited in Catholic care, it is plausible to think there are cases in which Catholic ethics have good reason to appraise the use of puberty blockers for gender non-conforming youths as obligatory. Read more.

Presented in 2023 at the second annual conference for the Society for Christian Bioethics

Rethinking Catholic Attitudes on Puberty Blockers

Ethical transgressions among healthcare professionals in South Africa from 2014 to 2023

with: M. Pontarelli, Y. Gezu, M. Nortje, G. Truong, N. Ravi, W.A. Hoffmann, and N. Nortje

Ethical transgressions by healthcare professionals disrupt patients’ perception of and trust in care providers who do act ethically. These transgressions not only impact the professionals themselves and their patients but also their respective specialties. Complaints of professional misconduct have shed light on the changes needed within various healthcare specialties to strengthen trust among the public and healthcare practitioners and to protect the patient– healthcare practitioner relationship. Exploring the frequency and types of reported ethical transgressions provides insight into areas requiring reform within specific healthcare sectors.

Available in Health SA Gesondheid

Secular Pluralism, Clinical Authoritarianism

It is unclear whether there exists a genuine “secular” authority which can function outside of religion, rather than as a particular variety of religion. I contend that while such an authority can exist with the legitimacy to arbitrate between competing religious traditions, this legitimacy quickly erodes within the context of the clinic. A popular thread within scholarship around religion holds that “secularity” is an instance of, rather than an alternative to, “religion” on the grounds that secularity—like all religions—is a moral-metaphysical worldview with an associated history of shared practices enduring over time. This thesis is defended in some form by Peter Harrison, John Milbank, Jeff Bishop, and others. I contend that this view fails to properly reflect the legitimating role of pluralism in cases where the secular tradition is not imposed onto a diverse community by an independent authority. The question I explore is whether the right-making features of the secular-religious distinction can endure in clinical settings. I conclude that while such features can endure in the clinic, genuine pluralism depends on ongoing negotiation between worldviews while the clinic often depends on autocratic dicta. Specifically, I contend that in a democratic pluralistic society, a tradition of acknowledging a common (though not necessarily universal) set of values and practices can reify such practices as the appropriate default commitments of that society for the purpose of legal and social conduct. While the secular is reified in this way, religious traditions are entitled to exemptions from it—a privilege uniquely held by those traditions. Conversely, the secular retains a privileged status of being able to adjudicate conflicts between religions. This exchange of privileges between the secular and the religious is legitimated by key features of a sufficiently free and diverse society, which is often presupposed by a pluralistic democracy. The clinic, by contrast, has several hallmarks of authoritarianism. Consequently, the conditions which legitimate secularity in public life are likely to vanish in the clinic - meaning the override of a religious preference by a clinician is liable to become merely an imposition of one religious worldview (i.e., the secular) over another, unjustly. In such cases the secular de re is lost and all that remains is the secular de dicto. The secular de dicto has no more legitimacy to arbitrate between religious traditions than any other religious tradition, yet often will continue to do so. When this occurs, harm is done, including spiritual violence against patients. I draw out the way the imposition of the de dicto secular can contribute to moral distress in cases of conscientious objection and patient noncompliance. By clarifying the conditions under which the secular and the religious are genuinely distinct, and by identifying the features of the clinic which undermine this distinction, I offer insights into how to best recognize when we are justified in overriding a sought religious exemption and when we are not.

Presented in 2026 at the Conference on Medicine and Religion

Caring for Bureaucracy: Duties to Neighbors in the Minimal State

To ground the legitimacy of the (minimal) state in a defense of rationality and rights presupposes, erroneously, that the state is a body separate from the people. I argue that we ought to regard our duties to the state as an outgrowth of our amalgamated duties to our neighbors. Moreover, what we owe the “state” is not conceptually distinct from what we owe our communities. In keeping with the tradition of care ethics, I argue that even in the minimal state, we have duties to act in a way which elevates the state’s power consistent with the needs of our neighbors. I aim to extend recent accounts of bureaucratic discretion by Daniel Engster and others, to a broader understanding of how best the citizenry should relate with their government in democratic societies. I further argue that this “raises the bar” on what good citizenship looks like in a democracy—to the point that most Americans likely are failing in their duties to others. This is meant to serve as both a rebuff of contemporary arguments in favor of a Nozickean minimal state and as a positive account of the duties we have to our government. These include the moral imperative of informed civil participation, direct political action, and defense of the civil service.

Presented in 2026 at the 35th Annual Meeting of the Association for Practical and Professional Ethics